First Trust Advisors LP Kodiak Sciences Inc. Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$45.05 - $59.27 $2.25 Million - $2.96 Million	-50,013 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$42.74 - $66.25 $216,392 - $335,423	5,063 Added 11.26%	50,013 $2.71 Million
Q1 2020 May 06, 2020	SELL	$38.18 - $73.95 $329,798 - $638,780	-8,638 Reduced 16.12%	44,950 $2.14 Million
Q4 2019 Feb 03, 2020	BUY	$13.9 - $76.65 $174,250 - $960,884	12,536 Added 30.54%	53,588 $3.86 Million
Q3 2019 Nov 04, 2019	BUY	$10.24 - $17.57 $420,372 - $721,283	41,052 New	41,052 $590,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $333M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.